Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
21.01
+0.03 (0.12%)
Nov 21, 2024, 10:44 AM EST - Market open
Jasper Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 315 | 88 | 22 | 389 | 125 | - |
| Market Cap Growth | 266.34% | 294.73% | -94.26% | 210.66% | - | - |
| Enterprise Value | 224 | -13 | -25 | 291 | 98 | - |
| Last Close Price | 20.98 | 7.89 | 4.83 | 78.50 | 100.10 | - |
| PB Ratio | 3.76 | 1.12 | 0.62 | 5.59 | 14.37 | - |
| P/TBV Ratio | 3.40 | 1.12 | 0.62 | 5.59 | - | - |
| Debt / Equity Ratio | 0.02 | 0.04 | 0.10 | 0.04 | 0.19 | - |
| Quick Ratio | 7.44 | 7.04 | 5.54 | 10.63 | 5.09 | 13.63 |
| Current Ratio | 7.61 | 7.19 | 5.91 | 10.95 | 5.16 | 13.63 |
| Return on Equity (ROE) | -71.46% | -112.67% | -71.44% | -78.33% | -212.46% | - |
| Return on Assets (ROA) | -40.92% | -60.09% | -45.06% | -39.35% | -51.13% | - |
| Return on Capital (ROIC) | -46.94% | -71.22% | -57.12% | -55.65% | -82.24% | - |
| Earnings Yield | -20.19% | -73.23% | -168.98% | -7.88% | -25.31% | - |
| FCF Yield | -18.63% | -59.45% | -208.21% | -9.29% | -14.60% | - |
| Buyback Yield / Dilution | -58.22% | -186.15% | -220.19% | -558.67% | - | - |
| Total Shareholder Return | -58.22% | -186.15% | -220.19% | -558.67% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.